The stock of Tabula Rasa HealthCare Inc. (NASDAQ:TRHC) increased by $0.01 on Tuesday to finish at $10.28, up 0.10 percent. The last five days have seen an average of 589,460 shares of common stock traded. 16 times new highs were reached in the current year, with a gain of $5.33. The average number of shares traded over the last 20 days was 755,745, while the average volume over the last 50 days totaled 370,912.
TRHC stock appreciated 28.02% since last month. On 08/03/23, the company’s shares reached a one-month low of $7.50. The stock touched a high of $10.37 on 08/07/23, after rallying from a low of $3.15 in 52 weeks. The price of TRHC stock has risen by 107.68% or $5.33 this year, reaching a new high 16 times. Still, the stock price is down -0.87% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
TRHC stock investors should be aware that Tabula Rasa HealthCare Inc. (TRHC) stock had its last reported insider trading activity 261 days ago on Dec 12. On Dec 12, CHIEF FINANCIAL OFFICER Cancro Thomas acquired 11,500 shares at $4.34 each. This transaction resulted in the insider spending $49,910. On Dec 09, Purcell Michael J. sold 10,000 shares at a price of US$4.26. After the transaction, the insider now owns 88,514 shares.
Financial Health
For the three months ended June 29, Tabula Rasa HealthCare Inc.’s quick ratio was 1.50, while its current ratio was 1.60, indicating its ability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 23.60% percent. Tabula Rasa HealthCare Inc.’s EBITDA margin for the year ended June 29 was -9.33%, whereas its operating margin stood at -16.60% for the same period. Based on annual data, it had gross profit of $66.91 million and revenue of $299.52 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. TRHC’s return on assets (ROA) during the last 12 months has been -25.50%. There was a -26.30% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 160.70%.
Earnings Surprise
According to Tabula Rasa HealthCare Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $90.04 million, while revenues rose by 19.37% to $88.28 million. It was predicted that Tabula Rasa HealthCare Inc.’s quarterly earnings would be $0.03, but it ended up being -$0.12, beating the consensus by 125.00%. EBITDA was -$2.59 million for the quarter. At the end of Tabula Rasa HealthCare Inc.’s most recent quarter ended June 29, its liabilities totaled 434.02 million, while its total debt was $341.97 million. Equity owned by shareholders amounts to $27.05 million.
Technical Picture
Here’s a quick look at Tabula Rasa HealthCare Inc.’s (TRHC) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 75.16%, suggesting the stock is Overbought, with a 3.06% historical volatility rate.
The stochastic %K and %D were 48.19% and 53.04% respectively, while the average true range (ATR) was 0.14. Based on the 14-day stochastic reading of 51.85%, the RSI (14) reading is 71.37%. On the 9-day MACD Oscillator, the stock is at 0.00, and the 14-day reading is at 0.01.
Analyst Ratings
In its most recent analyst report, SVB Securities raised its rating on Tabula Rasa HealthCare Inc. (NASDAQ: TRHC) to an Outperform. Prior to this, analysts firm rated the stock as a Market perform. Analysts have assigned Tabula Rasa HealthCare Inc. (TRHC) an Hold rating. TRHC is a stock that is recommended for selling by 0 brokerage firms, while 4 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 0 others recommend it as a buy.
What is TRHC’s price target for the next 12 months?
The current consensus forecast for the stock is between $10.50 and $10.50, with a median target price of $10.50. In analyzing these forecasts, the average price target given by analysts for Tabula Rasa HealthCare Inc. (TRHC) is $10.50.
